Earnings History Data for Emmaus Life Sciences (EMMA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Emmaus Life Sciences
Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2022 | PM | EMMA | Emmaus Life Sciences | 17.00 | -0.01 | 0.01 | 0.00 | Emmaus Life Sciences GAAP EPS of -$0.01, revenue of $4.94M [11/15/2022 8:32 AM] |
0.30 | -0.08 (-20.00%) |
0.0 | 0.0 (0.00%) |
0.07 - 4.00 | 5,566 | 0 | 0 | ||
| 15-08-2022 | AH | EMMA | Emmaus Life Sciences | 20.00 | -0.18 | 0.01 | 0.00 | Emmaus Life Sciences GAAP EPS of -$0.18, revenue of $4.3M misses by $1.7M [8/15/2022 5:15 PM] |
0.37 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.25 - 4.00 | 9,000 | 0 | 0 | ||
| 31-03-2022 | AH | EMMA | Emmaus Life Sciences | 64.00 | -0.14 | 0.05 | 0.00 | Emmaus Life Sciences GAAP EPS of -$0.32, revenue of $20.62M [3/31/2022 5:36 PM] |
1.00 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.90 - 4.00 | 18,012 | 0 | 0 | ||